All Studies

Identification of apposite antagonist for androgen receptor in prostate cancer: an in silico study of fenugreek compounds.

Fenugreek compounds were tested for their potential as anti-cancer agents on benign prostate cancer by targeting the androgen receptor. The compounds chlorogenic acid and kaempferol showed the most promise, indicating their potential for drug development in BPC treatment. (25 words)

Olugbogi EA et al (2023).
J Biomol Struct Dyn.
PubMed:
37897191

Albocycline Is the Main Bioactive Antifungal Compound Produced by Streptomyces sp. OR6 against Verticillium dahliae.

Actinobacteria from olive tree soil can potentially control Verticillium wilt. One strain, sp. OR6, produced albocycline which effectively inhibited the pathogen's growth. This marks the first evidence of albocycline's efficacy against Verticillium wilt, highlighting its potential as a biocontrol agent.

Calvo-Peña C et al (2023).
Plants (Basel).
PubMed:
37896074